# Spruce (SPRB) — News

SPRB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sprb/news

## Recent headlines

- [Quebecor Inc.: National Bank of Canada cuts target price to C$71 from C$74](https://www.ainvest.com/news/quebecor-national-bank-canada-cuts-target-price-71-74-2610) — AInvest Wire, Oct 13, 2026
  National Bank of Canada has revised its target price for Quebecor Inc. (TSE:QBR.B) to C$71 from C$74, reflecting a slight downward adjustment in its valuation outlook for the company. The move suggests a recalibration of expectations, potentially influenced by recent market dynamics or internal…
- [Spruce Biosciences: Ta-ert EAP and transform study expected to initiate in Q4 2026](https://www.ainvest.com/news/spruce-biosciences-ta-ert-eap-transform-study-expected-initiate-q4-2026-2608) — AInvest Wire, Aug 26, 2026
  Spruce Biosciences, Inc. (Nasdaq: SPRB) has confirmed that its planned Biologics License Application (BLA) for tralesinidase alfa enzyme replacement therapy (TA-ERT) remains on track for submission in the fourth quarter of 2026, following positive pre-BLA meetings with the FDA . The company has…
- [Spruce: confirms BLA submission for TA-ERT on track for 4Q](https://www.ainvest.com/news/spruce-confirms-bla-submission-ta-ert-track-4q-2608) — AInvest Wire, Aug 24, 2026
  Spruce Biosciences, Inc. (Nasdaq: SPRB) has confirmed that its Biologics License Application (BLA) submission for tralesinidase alfa enzyme replacement therapy (TA-ERT) remains on track for the fourth quarter of 2026. The company recently concluded two Type B meetings with the U.S. Food and Drug…
- [Spruce Biosciences: positive pre-BLA meetings with FDA](https://www.ainvest.com/news/spruce-biosciences-positive-pre-bla-meetings-fda-2608) — AInvest Wire, Aug 24, 2026
- [Spruce Biosciences: FDA and Spruce aligned on content and format of planned BLA](https://www.ainvest.com/news/spruce-biosciences-fda-spruce-aligned-content-format-planned-bla-2608) — AInvest Wire, Aug 24, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).